BII
GILD icon

Baring International Investment’s Gilead Sciences GILD Stock Holding History

Baring International Investment’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		$14.1M Sell
169,505
-35,469
-17% -$2.76M 0.89% 32
2014
Q1 		$14.5M Buy
+204,974
New +$16.1M 0.85% 42

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Baring International Investment's GILD Position: Q2 2014 in Review

Baring International Investment reduced its Gilead Sciences (GILD) stake by 17% in Q2 2014, selling an estimated $2.76M and leaving 169,505 shares worth $14.1M. The position accounts for 0.89% of the portfolio, ranked #32.

Baring International Investment first reported a position in GILD in Q1 2014 and has held it in 2 quarters since. The position peaked at $14.5M in Q1 2014. 1,263 funds tracked by Wall St. Rank hold GILD as of Q2 2014.

  • Baring International Investment held 169,505 shares of Gilead Sciences worth $14.1M as of Q2 2014.
  • Baring International Investment sold 35,469 Gilead Sciences shares in Q2 2014, an estimated $2.76M.
  • Gilead Sciences made up 0.89% of Baring International Investment's portfolio in Q2 2014, its #32 holding.
  • Baring International Investment first reported a position in Gilead Sciences in Q1 2014 and has held it in 2 quarters since.
  • Baring International Investment's Gilead Sciences position peaked at $14.5M in Q1 2014.
  • 1,263 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2014.

Based on Baring International Investment's 13F filing for Q2 2014, filed 21 Jul 2014.